[Comparative study of acebutolol and propranolol in the treatment of arterial hypertension].
This double-blind clinical study was carried out in order to compare the therapeutic activity of propranolol, and a new beta-adrenergic blocker, acebutolol, in essential hypertension. The hypotensive activity of acebutolol was confirmed when a dosage of 600 mg/day was used, with en absence of side effects.
D000070:Acebutolol / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D011433:Propranolol / Q000627:therapeutic use*
D000070:Acebutolol; D011433:Propranolol
Etude comparative de l'acébutolol et du propranolol dans le traitement de l'hypertension artérielle